Oximio (Formerly SMO Group) is a clinical trial services provider contributing to research to find effective treatment and cures for all living beings, globally. Oximio works hard to convert the ever-changing face of investigational medical products into new medicines, bringing over 19 years of service excellence to the clinical trial industry. The company provides a direct connection to several patient communities of over 500 million people by being present in the United Kingdom, Eastern Europe, Western Asia, and South Africa. Oximio’s large and loyal client base ranges from start-ups to major international organizations, pharmaceutical and R&D companies. Oximio is in the front line of servicing clinical trials with own warehouses and, through licensed partner sites, offers an end-to-end cold-chain control system in all premises. By combining its’ ‘best-in-class’ depot network with a highly experienced and qualified workforce, Oximio is thoroughly conversant with both global and local procedures for clinical trials, ensuring the highest standards of operation. Oximio has the following capabilities: supply planning and consulting, comparator sourcing, patient centricity, advanced therapy solutions, import & export regulations, relabelling, warehousing, distribution and courier services, return & destruction. 

Clinical Trials

Life Sciences

Logistics & Supply Chain

Pharmaceutical

Oximio (Formerly SMO Group)

Oximio (Formerly SMO Group)'s headquarters in Huntingdon, Cambridgeshire, United Kingdom

Description

People (8)

Mark Woolf

Sahina Mohsin

Zayheda Khan

Zayheda Khan

Pawel Drozd

Alison Winn

Tim J.

Kelly Toma

Jobs